Xelstrym to Launch Soon: New FDA-Approved ADHD Stimulant Patch
Xelstrym is the first FDA-approved transdermal amphetamine patch to treat pediatric and adult patients with ADHD. It is expected to launch later this year.
Xelstrym is the first FDA-approved transdermal amphetamine patch to treat pediatric and adult patients with ADHD. It is expected to launch later this year.